Dianthus expects Phase 2 MoMeNtum results for claseprubart in MMN in December; plans Phase 3 in 2027

Dianthus Therapeutics says it expects Phase 2 MoMeNtum results for claseprubart in MMN in December and plans to start a Phase 3 trial in 2027.

Detected & updated continuously · Source: Nebula